{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T13:27:17Z","timestamp":1782307637388,"version":"3.54.5"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["EMIDDT"],"published-print":{"date-parts":[[2013,3,1]]},"DOI":"10.2174\/1871530311313010012","type":"journal-article","created":{"date-parts":[[2013,3,20]],"date-time":"2013-03-20T02:31:01Z","timestamp":1363746661000},"page":"100-104","source":"Crossref","is-referenced-by-count":21,"title":["Parathyroid Hormone and Heart Failure: Novel Biomarker Strategy"],"prefix":"10.2174","volume":"13","author":[{"given":"Hakan","family":"Altay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucel","family":"Colkesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Endocrine, Metabolic & Immune Disorders-Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/108131","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T09:56:40Z","timestamp":1448272600000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1871-5303&volume=13&issue=1&spage=100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,3,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871530311313010012","relation":{},"ISSN":["1871-5303"],"issn-type":[{"value":"1871-5303","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3,1]]}}}